Inactive Instrument

Cyprotex plc Stock

Equities

GB0031214470

Biotechnology & Medical Research

End-of-day quote London S.E. Other stock markets
- ^GBX	-

2013

Cyprotex plc : Drug testing firm Cyprotex eyes deals after raising 7 million pounds

RE

on all our subscriptions*

Take advantage of the offer

* See conditions on site

Latest news about Cyprotex plc

Cyprotex plc : Drug testing firm Cyprotex eyes deals after raising 7 million pounds

13-08-07

RE

Press releases Cyprotex plc

Cyprotex : extends its metabolite identification service to support human clinical samples	16-09-13	PU
Cyprotex : extends is metabolite identification service	16-09-13	PU
Cyprotex : expand ADME capabilities with the introduction of 8 additional transporter assays	16-09-08	PU
Cyprotex : Launch New Endocrine Disruption Service	16-07-07	PU
Cyprotex : Launch of chemTarget for Predicting Biological Target Interaction directly from Chemical Structure	16-06-23	PU

More press releases

News in other languages on Cyprotex plc

Evotec will britisches Forschungsunternehmen kaufen

16-10-26

Managers and Directors - Cyprotex plc

Managers	Title	Age	Since
Christian Dargel SEC	Corporate Secretary	-	21-04-12

Members of the board	Title	Age	Since
Craig Johnstone BRD	Director/Board Member	54	-
Stephen Madden BRD	Director/Board Member	-	23-03-27

Company Profile

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
MODERNA, INC.	+17.96%	44.96B
LONZA GROUP AG	+48.77%	41.85B
IQVIA HOLDINGS INC.	+1.17%	42.65B
CELLTRION, INC.	-4.27%	29.04B
ICON PUBLIC LIMITED COMPANY	+11.42%	26.08B
ALNYLAM PHARMACEUTICALS, INC.	-21.39%	19.03B
BIO-TECHNE CORPORATION	+4.86%	12.75B
MEDPACE HOLDINGS, INC.	+27.29%	12.06B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.50%	11.75B

Other Biotechnology & Medical Research

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW